Anthony Y.H. Lu

11.3k total citations · 4 hit papers
122 papers, 8.8k citations indexed

About

Anthony Y.H. Lu is a scholar working on Pharmacology, Molecular Biology and Oncology. According to data from OpenAlex, Anthony Y.H. Lu has authored 122 papers receiving a total of 8.8k indexed citations (citations by other indexed papers that have themselves been cited), including 80 papers in Pharmacology, 49 papers in Molecular Biology and 39 papers in Oncology. Recurrent topics in Anthony Y.H. Lu's work include Pharmacogenetics and Drug Metabolism (79 papers), Drug Transport and Resistance Mechanisms (34 papers) and Genomics, phytochemicals, and oxidative stress (14 papers). Anthony Y.H. Lu is often cited by papers focused on Pharmacogenetics and Drug Metabolism (79 papers), Drug Transport and Resistance Mechanisms (34 papers) and Genomics, phytochemicals, and oxidative stress (14 papers). Anthony Y.H. Lu collaborates with scholars based in United States, Switzerland and Canada. Anthony Y.H. Lu's co-authors include Wayne Levin, Jiunn H. Lin, Susan West, Qiang Ma, Deborah J. Newton, J H Lin, Gerald T. Miwa, R. Kuntzman, Allan H. Conney and Henry W. Strobel and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Anthony Y.H. Lu

121 papers receiving 8.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inhibition and Induction of Cytochrome P450 and the Clinical Implications

1998 642 citations Anthony Y.H. Lu et al. profile →
Cytochrome P450 inhibitors. Evaluation of specificities in the in vitrometabolism of therapeutic agents by human liver microsomes.

1995 562 citations Deborah J. Newton, Anthony Y.H. Lu et al. Drug Metabolism and Disposition profile →
Role of Pharmacokinetics and Metabolism in Drug Discovery and Development

1997 517 citations Anthony Y.H. Lu et al. Pharmacological Reviews profile →
Phosphatidylcholine Requirement in the Enzymatic Reduction of Hemoprotein P-450 and in Fatty Acid, Hydrocarbon, and Drug Hydroxylation

1970 387 citations Anthony Y.H. Lu et al. profile →

Peers

Anthony Y.H. Lu

PHARM

ONCOL

BIOCH

Laurence S. Kaminsky United States

Sidney D. Nelson United States

Dene E. Ryan United States

Thomas K. H. Chang United States

David J. Jollow United States

Ronald W. Estabrook United States

Hannu Raunio Finland

Paul E. Thomas United States

Yasushi Yamazoe Japan

M.D. Burke United Kingdom

Laurence S. Kaminsky United States

Anthony Y.H. Lu

5.6k ×1.0

PHARM

3.0k ×1.0

2.6k ×1.1

ONCOL

1.1k ×1.0

BIOCH

1.1k ×1.3

Citations per year, relative to Anthony Y.H. Lu Anthony Y.H. Lu (= 1×) peers Laurence S. Kaminsky

Countries citing papers authored by Anthony Y.H. Lu

Since Specialization

Citations

This map shows the geographic impact of Anthony Y.H. Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony Y.H. Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony Y.H. Lu more than expected).

Fields of papers citing papers by Anthony Y.H. Lu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anthony Y.H. Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony Y.H. Lu. The network helps show where Anthony Y.H. Lu may publish in the future.

Co-authorship network of co-authors of Anthony Y.H. Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Anthony Y.H. Lu. A scholar is included among the top collaborators of Anthony Y.H. Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anthony Y.H. Lu. Anthony Y.H. Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lu, Anthony Y.H., et al.. (2022). A MIDDLE-AGED PATIENT WITH BILATERAL VISION LOSS AND NYCTALOPIA. Retinal Cases & Brief Reports. 17(4S). S19–S22. 1 indexed citations

Khojasteh, S. Cyrus, Saileta Prabhu, Jane R. Kenny, Jason Halladay, & Anthony Y.H. Lu. (2011). Chemical inhibitors of cytochrome P450 isoforms in human liver microsomes: a re-evaluation of P450 isoform selectivity. European Journal of Drug Metabolism and Pharmacokinetics. 36(1). 1–16. 116 indexed citations

Ma, Qiang & Anthony Y.H. Lu. (2011). Pharmacogenetics, Pharmacogenomics, and Individualized Medicine. Pharmacological Reviews. 63(2). 437–459. 323 indexed citations

Tang, Wei & Anthony Y.H. Lu. (2009). Metabolic bioactivation and drug-related adverse effects: current status and future directions from a pharmaceutical research perspective. Drug Metabolism Reviews. 42(2). 225–249. 53 indexed citations

Shou, Magang & Anthony Y.H. Lu. (2009). Antibodies as a Probe in Cytochrome P450 Research. Drug Metabolism and Disposition. 37(5). 925–931. 5 indexed citations

Ma, Qiang & Anthony Y.H. Lu. (2007). CYP1A Induction and Human Risk Assessment: An Evolving Tale of in Vitro and in Vivo Studies. Drug Metabolism and Disposition. 35(7). 1009–1016. 181 indexed citations

Tang, Wei, Regina W. Wang, & Anthony Y.H. Lu. (2005). Utility of Recombinant Cytochrome P450 Enzymes: A Drug Metabolism Perspective. Current Drug Metabolism. 6(5). 503–517. 28 indexed citations

He, Xiaoyang, et al.. (2004). IDENTIFICATION OF CRITICAL AMINO ACID RESIDUES OF HUMAN CYP2A13 FOR THE METABOLIC ACTIVATION OF 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE, A TOBACCO-SPECIFIC CARCINOGEN. Drug Metabolism and Disposition. 32(12). 1516–1521. 36 indexed citations

Newton, Deborah J., et al.. (1995). Cytochrome P450 inhibitors. Evaluation of specificities in the in vitrometabolism of therapeutic agents by human liver microsomes.. Drug Metabolism and Disposition. 23(1). 154–158. 562 indexed citations breakdown →

10.

Newton, Deborah J., et al.. (1993). Fluorescence characterization of Trp 21 in rat glutathione S‐transferase 1–1: Microconformational changes induced by S‐hexyl glutathione. Protein Science. 2(12). 2085–2094. 13 indexed citations

11.

Wang, Regina W., Deborah J. Newton, Cecil B. Pickett, & Anthony Y.H. Lu. (1992). Site-directed mutagenesis of glutathione S-transferase YaYa: Functional studies of histidine, cysteine, and tryptophan mutants. Archives of Biochemistry and Biophysics. 297(1). 86–91. 17 indexed citations

12.

Álvaro, Raúl, Peter G. Wislocki, Gerald T. Miwa, & Anthony Y.H. Lu. (1992). Drug residue formation from ronidazole, a 5-nitroimidazole. VIII. Identification of the 2-methylene position as a site of protein alkylation. Chemico-Biological Interactions. 82(1). 21–30. 16 indexed citations

13.

Wang, Regina W., Deborah J. Newton, Cecil B. Pickett, & Anthony Y.H. Lu. (1991). Site-directed mutagenesis of glutathione S-transferase YaYa: Nonessential role of histidine in catalysis. Archives of Biochemistry and Biophysics. 286(2). 574–578. 24 indexed citations

14.

Kari, Prasad H., et al.. (1991). Biotransformation of lovastatin. Archives of Biochemistry and Biophysics. 290(2). 355–361. 166 indexed citations

15.

Lu, Anthony Y.H., Shuet‐Hing Lee Chiu, & Peter G. Wislocki. (1990). Development of a Unified Approach to Evaluate the Topological Potential of Bound Residues. Drug Metabolism Reviews. 22(6-8). 891–904. 3 indexed citations

16.

Huskey, Su-Er W., et al.. (1990). Expression in Escherichia coli of rat liver cytosolic glutathione S-transferase Yc cDNA. Archives of Biochemistry and Biophysics. 279(1). 116–121. 4 indexed citations

17.

Pickett, C B, et al.. (1989). Expression of a cDNA encoding a rat liver glutathione S-transferase Ya subunit in Escherichia coli. Archives of Biochemistry and Biophysics. 269(2). 536–543. 26 indexed citations

18.

Wang, Regina W., et al.. (1988). In vitro studies on the interaction of famotidine with liver microsomal cytochrome P-450. Biochemical Pharmacology. 37(15). 3049–3053. 7 indexed citations

19.

Chiu, Shuet‐Hing Lee, et al.. (1987). Comparative in Vivoand in Vitro Metabolism of Ivermectin in Steers, Sheep, Swine, and Rat. Drug Metabolism Reviews. 18(2-3). 289–302. 45 indexed citations

20.

Lu, Anthony Y.H., Susan West, Dene E. Ryan, & Wayne Levin. (1973). CHARACTERIZATION OF PARTIALLY PURIFIED CYTOCHROMES P-450 AND P-448 FROM RAT LIVER MICROSOMES. Drug Metabolism and Disposition. 1(1). 29–39. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact